InvestorsHub Logo
Followers 19
Posts 727
Boards Moderated 0
Alias Born 11/10/2009

Re: grandma_of_jbraika post# 2189

Thursday, 09/30/2010 8:36:39 AM

Thursday, September 30, 2010 8:36:39 AM

Post# of 80490
The question is nonsensical. Beyond the milestone payments, Ariad receives tiered double digit royalties on sales of Ridaforolimus...period, end of discussion. If you have further questions on this matter, I suggest you review the company's filings regarding this matter:

"Merck will book global sales of ridaforolimus and pay ARIAD tiered double-digit royalties on global net sales of ridaforolimus. In addition to now receiving royalties on U.S. sales in lieu of a profit split, these global royalty rates are approximately one-third greater than the royalty rates that ARIAD would have received for ex-U.S. sales under the original collaboration agreement with Merck."

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.